These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15814729)

  • 1. IL-1beta-mediated innate immunity is amplified in the db/db mouse model of type 2 diabetes.
    O'Connor JC; Satpathy A; Hartman ME; Horvath EM; Kelley KW; Dantzer R; Johnson RW; Freund GG
    J Immunol; 2005 Apr; 174(8):4991-7. PubMed ID: 15814729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness.
    Johnson DR; O'Connor JC; Dantzer R; Freund GG
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15184-9. PubMed ID: 16217019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor.
    Touzani O; Boutin H; LeFeuvre R; Parker L; Miller A; Luheshi G; Rothwell N
    J Neurosci; 2002 Jan; 22(1):38-43. PubMed ID: 11756486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8.
    Li S; Neff CP; Barber K; Hong J; Luo Y; Azam T; Palmer BE; Fujita M; Garlanda C; Mantovani A; Kim S; Dinarello CA
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2497-502. PubMed ID: 25654981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losartan inhibits LPS + ATP-induced IL-1beta secretion from mouse primary macrophages by suppressing NALP3 inflammasome.
    Wang F; Huang L; Peng ZZ; Tang YT; Lu MM; Peng Y; Mel WJ; Wu L; Mo ZH; Meng J; Tao LJ
    Pharmazie; 2014 Sep; 69(9):680-4. PubMed ID: 25272939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist.
    Lundkvist J; Sundgren-Andersson AK; Tingsborg S; Ostlund P; Engfors C; Alheim K; Bartfai T; Iverfeldt K; Schultzberg M
    Am J Physiol; 1999 Mar; 276(3):R644-51. PubMed ID: 10070123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of IL-18 in the secretion of Il-1beta, sIL-1RII, and IL-1Ra by human neutrophils.
    Jablonska E; Izycka A; Jablonska J; Wawrusiewicz N; Piecuch J
    Immunol Invest; 2001 Aug; 30(3):221-9. PubMed ID: 11570642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice.
    Bluthé RM; Layé S; Michaud B; Combe C; Dantzer R; Parnet P
    Eur J Neurosci; 2000 Dec; 12(12):4447-56. PubMed ID: 11122355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice.
    Zykova SN; Jenssen TG; Berdal M; Olsen R; Myklebust R; Seljelid R
    Diabetes; 2000 Sep; 49(9):1451-8. PubMed ID: 10969828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines.
    Henry CJ; Huang Y; Wynne AM; Godbout JP
    Brain Behav Immun; 2009 Mar; 23(3):309-17. PubMed ID: 18814846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxycycline inhibition of interleukin-1 in the corneal epithelium.
    Solomon A; Rosenblatt M; Li DQ; Liu Z; Monroy D; Ji Z; Lokeshwar BL; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2544-57. PubMed ID: 10937565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPS-dependent suppression of social exploration is augmented in type 1 diabetic mice.
    Lin KI; Johnson DR; Freund GG
    Brain Behav Immun; 2007 Aug; 21(6):775-82. PubMed ID: 17321107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of IL-1alpha and IL-1beta in ischemic brain damage.
    Boutin H; LeFeuvre RA; Horai R; Asano M; Iwakura Y; Rothwell NJ
    J Neurosci; 2001 Aug; 21(15):5528-34. PubMed ID: 11466424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide-induced down-regulation of organic anion transporting polypeptide 4 (Oatp4; Slc21a10) is independent of tumor necrosis factor-alpha, Interleukin-1beta, interleukin-6, or inducible nitric oxide synthase.
    Li N; Klaassen CD
    Toxicol Sci; 2005 Jan; 83(1):197-203. PubMed ID: 15483191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IL-1(beta) in endotoxin potentiation of deoxynivalenol-induced corticosterone response and leukocyte apoptosis in mice.
    Islam Z; Pestka JJ
    Toxicol Sci; 2003 Jul; 74(1):93-102. PubMed ID: 12773775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1beta-dependent neurological effects of the whole cell pertussis vaccine: a role for IL-1-associated signalling components in vaccine reactogenicity.
    Armstrong ME; Loscher CE; Lynch MA; Mills KH
    J Neuroimmunol; 2003 Mar; 136(1-2):25-33. PubMed ID: 12620640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related reciprocal modulation of interleukin-1beta and interleukin-1 receptors in the mouse brain-endocrine-immune axis.
    Takao T; Nagano I; Tojo C; Takemura T; Makino S; Hashimoto K; De Souza EB
    Neuroimmunomodulation; 1996; 3(4):205-12. PubMed ID: 9094441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression.
    Layé S; Gheusi G; Cremona S; Combe C; Kelley K; Dantzer R; Parnet P
    Am J Physiol Regul Integr Comp Physiol; 2000 Jul; 279(1):R93-8. PubMed ID: 10896869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
    Gabay C; Porter B; Fantuzzi G; Arend WP
    J Immunol; 1997 Dec; 159(12):5905-13. PubMed ID: 9550387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes impairs insulin receptor substrate-2-mediated phosphatidylinositol 3-kinase activity in primary macrophages to induce a state of cytokine resistance to IL-4 in association with overexpression of suppressor of cytokine signaling-3.
    O'Connor JC; Sherry CL; Guest CB; Freund GG
    J Immunol; 2007 Jun; 178(11):6886-93. PubMed ID: 17513737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.